Hexagon Nutrition auditor flags going-concern uncertainty

Hexagon Nutrition Limited said its South African and Uzbekistan subsidiaries had combined net liabilities of Rs 12.516 crore at September 30, 2026, and its auditor identified a material uncertainty that may cast significant doubt on their ability to continue as going concerns. Management nevertheless prepared the consolidated results on a going-concern basis.

Why did Hexagon Nutrition’s auditor flag the two overseas subsidiaries?

The auditor flagged Hexagon Nutrition’s South African and Uzbekistan subsidiaries because historical accumulated losses had produced combined net liabilities of Rs 12.516 crore as of September 30, 2026. The entities named in Note 7 are Hexagon Nutrition Proprietary Ltd in South Africa and Hexagon Nutrition LLC in Uzbekistan, both of which are wholly owned subsidiaries.

S K Patodia & Associates LLP stated in its November 14, 2026 limited-review report that the matters at the two subsidiaries indicate a material uncertainty that may cast significant doubt on their ability to continue as going concerns. The auditor drew attention to Note 7 but did not modify its conclusion on the consolidated unaudited financial results for the quarter and half year ended September 30, 2026.

A going-concern basis means the financial statements are prepared on the assumption that an entity will continue operating and meet obligations as they fall due. The auditor’s report said nothing had come to its attention that suggested the consolidated results contained a material misstatement or failed to make disclosures required under Regulation 33 of the Securities and Exchange Board of India listing regulations.

What financial information is available on Hexagon Nutrition’s overseas subsidiaries?

Hexagon Nutrition disclosed the Rs 12.516 crore combined net-liability position for the South African and Uzbek companies but did not provide separate revenue, debt, cash-flow or balance-sheet figures for either entity. Note 7 attributes the deficit to historical accumulated losses and says their long-term sustainability remains subject to regional market dynamics.

The filing identifies uncertainty over future cash flows and the ability to settle future liabilities and operational obligations when due. It does not state whether South Africa or Uzbekistan accounts for the larger part of the combined net liabilities, nor does it quantify any funding requirement for the two subsidiaries after September 30, 2026.

The auditor also reported management-certified, unaudited information for three foreign subsidiaries, which includes the South African, Uzbek and Hong Kong operations. Their aggregate results cannot be attributed individually to the two entities covered by the going-concern disclosure.

What is Hexagon Nutrition doing to address the uncertainty?

Hexagon Nutrition management said it has initiated strategic interventions to revive business performance, enhance revenue streams and optimise cost structures across its overseas operations as of the September 30, 2026 results. The filing does not disclose a revenue target, cost-saving target, timetable, capital commitment or subsidiary-specific implementation plan.

Management said it retains a reasonable expectation of the entities’ long-term viability and therefore prepared the consolidated financial results on a going-concern basis. That is management’s assessment, while the same Note 7 says that long-term sustainability remains dependent on regional market dynamics and future cash flows.

Hexagon Nutrition operates in one reportable business segment, manufacturing of nutraceutical products, under Indian Accounting Standard 108, or Ind AS 108. This single-segment presentation means the filing does not separately identify sales, profit, assets or operating cash flow from South Africa and Uzbekistan.

How did Hexagon Nutrition’s first-half consolidated results change?

Hexagon Nutrition’s revenue from operations rose to Rs 213.967 crore in the half year ended September 30, 2026 from Rs 168.045 crore a year earlier, while net profit after tax declined to Rs 16.238 crore from Rs 16.592 crore. Profit before tax also fell to Rs 20.75 crore from Rs 21.808 crore despite the higher revenue.

The half-year comparison includes exceptional expenses of Rs 1.071 crore in 2026, against exceptional income of Rs 3.7 lakh in the corresponding 2025 period. The company said comparative figures had been restated after the merger of Hexagon Nutrition (Exports) Private Limited into Hexagon Nutrition under the pooling-of-interests method, so they are not directly comparable with financial information previously reported for those periods.

Operating cash flow moved further into outflow during the September 2026 half year, with net cash used rising to Rs 8.584 crore from Rs 1.077 crore a year earlier. Inventories increased by Rs 52.244 crore, compared with an increase of Rs 13.01 crore in the prior-year half, while cash and cash equivalents were Rs 14.282 crore at September 30, 2026 versus Rs 15.774 crore at March 31, 2026.

What other September 2026 disclosures affect Hexagon Nutrition’s results?

Hexagon Nutrition initiated phased decommissioning and operational restructuring at its Premix manufacturing facility in Nashik, Maharashtra, during the quarter ended September 30, 2026. The resulting property, plant and equipment derecognition, impairment and disposal were recorded within exceptional items, which were Rs 1.133 crore in the September quarter and Rs 1.071 crore for the half year.

The company’s equity shares were listed on the National Stock Exchange of India Limited and BSE Limited on June 12, 2026, following a 100% offer for sale by existing shareholders. The offer covered 3,08,59,704 shares at Rs 45 per share and aggregated Rs 138.87 crore, while outstanding compulsorily convertible preference shares were converted into equity during the quarter ended June 30, 2026.

These listing and capital-structure events do not address the auditor’s September 30, 2026 disclosure on the two overseas subsidiaries. The source does not disclose a guarantee, loan, equity infusion or other committed support arrangement for the South African and Uzbek entities.

Conclusion

Hexagon Nutrition reported revenue growth to Rs 213.967 crore for the half year ended September 30, 2026, but its South African and Uzbekistan subsidiaries carried combined net liabilities of Rs 12.516 crore. Management has outlined revenue and cost actions and retained going-concern accounting, while the auditor has highlighted material uncertainty around the entities’ future cash flows and ability to meet obligations.

The next results should show whether management’s interventions produce a change in the overseas operations’ financial position, cash flows or liabilities. Readers can also watch for disclosures on regional market conditions, funding support for the subsidiaries, and the future financial effect of the Nashik Premix facility restructuring initiated in the September 2026 quarter.